ProfileGDS4459 / ENSG00000188263
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 38% 17% 28% 24% 23% 25% 28% 25% 30% 26% 26% 22% 26% 19% 28% 44% 7% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 14.0438
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 23.2917
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 33.428
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 43.6324
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 53.2623
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 63.4525
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 73.4328
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 83.325
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 93.5430
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 103.3826
GSM623474group B, liver allograft wedge biopsie placebo treatment 13.4326
GSM623475group B, liver allograft wedge biopsie placebo treatment 23.0722
GSM623476group B, liver allograft wedge biopsie placebo treatment 33.4226
GSM623477group B, liver allograft wedge biopsie placebo treatment 43.3919
GSM623478group B, liver allograft wedge biopsie placebo treatment 53.4228
GSM623479group B, liver allograft wedge biopsie placebo treatment 64.2244
GSM623480group B, liver allograft wedge biopsie placebo treatment 72.757